Trial site
Japanese Red Cross Osaka Hospital
- 10running trials
- 4closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Multiple myeloma4 trials
- Ulcerative colitis4 trials
- Crohn's disease3 trials
- Acute myeloid leukaemia1 trial
- Bladder cancer1 trial
- Myasthenia gravis1 trial
- Phase
- Phase 38 trials
- Phase 23 trials
- Phase 2/32 trials
- Phase 1/21 trial
- Status
- Active, not recruiting7 trials
- Completed4 trials
- Recruiting3 trials
- Lead sponsor
- Janssen Research & Development, LLC11 trials
- Janssen Pharmaceutical K.K.1 trial
- Protara Therapeutics1 trial
- Regeneron Pharmaceuticals1 trial
Running trials
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Bladder cancer1 recruiting
- Crohn's disease1 recruiting
Closed trials
Completed
A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis
Completed
A Study of Teclistamab in Japanese Participants With Relapsed or Refractory Multiple Myeloma
Recruiting
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026